Delivery of Anticancer Molecules Using Carbon Nanotubes

  • Isma Ahmed
  • Aneela Javeed
  • Waqar Ahmed
  • D. A. Phoenix
  • Abdelbary ElhissiEmail author
  • Mark J. Jackson


Since their discovery in 1991, carbon nanotubes (CNTs) have emerged as material structures with numerous potential applications with a number of products already in the market place. An exciting application, which is emerging, is the use of carbon nanotubes for drug delivery. In this chapter, we focus on the functionalization, mechanism of cellular update, and using carbon nanotubes for delivery of anticancer drugs.


  1. 1.
    Iijima, S. (1991). Helical microtubules of graphitic carbon. Letters to Nature, 354, 56–58.CrossRefGoogle Scholar
  2. 2.
    Sahooa, N. G., Ranab, S., Chob, J. W., Lia, L., & Chana, S. H. (2010). Polymer nanocomposites based on functionalized carbon nanotubes. Progress in Polymer Science, 35, 837–867.CrossRefGoogle Scholar
  3. 3.
    Ajayan, P. M., Stephan, O., Colliex, C., & Trauth, D. (1994). Aligned carbon nanotube arrays formed by cutting a polymer resin-nanotube composite. Science, 265, 1212–1214.CrossRefGoogle Scholar
  4. 4.
    Coleman, J. N., Khan, U., Blau, W. J., & Gun’ko, Y. K. (2006). Small but strong: A review of the mechanical properties of carbon nanotubes—polymer composites. Carbon, 44, 1624–1652.CrossRefGoogle Scholar
  5. 5.
    Valentin, N. P. (2004). Carbon nanotubes: Properties and application. Materials Science and Engineering, 43, 61–102.CrossRefGoogle Scholar
  6. 6.
    Plank, N. O. V., & Cheung, R. (2004). Functionalisation of carbon nanotubes for molecular electronics. Microelectronic Engineering, 73, 578–582.CrossRefGoogle Scholar
  7. 7.
    Star, A., Stoddart, J. F., Steuerman, D., Diehl, M., Boukai, A., Wong, E., et al. (2001). Preparation and properties of polymer-wrapped single-walled carbon nanotubes. Angewandte Chemie International, 40, 1721–1725.CrossRefGoogle Scholar
  8. 8.
    Bianco, A., Kostarelos, K., & Prato, M. (2005). Application of carbon nanotubes in drug delivery. Current Opinion in Chemical Biology, 9, 674–679.CrossRefGoogle Scholar
  9. 9.
    Elhissi, A. M., Ahmed, W., Ul Hassan, I., Dhanak, V. R., & D’Emanuele, A. (2012). Carbon nanotubes in cancer therapy and drug delivery. Journal of Drug Delivery, 2012. Article ID 837327.Google Scholar
  10. 10.
    Cho, K., Wang, X., Nie, S., Chen, Z., & Shin, D. M. (2008). Therapeutic nanoparticles for drug delivery in cancer. Clinical Cancer Research, 5, 1310–1316.CrossRefGoogle Scholar
  11. 11.
    Raffa, V., Ciofani, G., Vittorio, O., Riggio, C., & Cuschieri, A. (2010). Physicochemical properties affecting cellular uptake of carbon nanotubes. Nanomedicine, 1, 89–97.CrossRefGoogle Scholar
  12. 12.
    Faraji, H. A., & Wipf, P. (2009). Nanoparticles in cellular drug delivery. Bioorganic & Medicinal Chemistry, 17, 2950–2962.CrossRefGoogle Scholar
  13. 13.
    Jiang, W., Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2008). Nanoparticles-mediated cellular response is size-dependent. Nature Nanotechnology, 3, 145–150.CrossRefGoogle Scholar
  14. 14.
    Shi Kam, N. W., & Dai, H. (2005). Carbon nanotubes as intracellular protein transporters: Generality and biological functionality. Journal of the American Chemical Society, 127, 6021–6026.CrossRefGoogle Scholar
  15. 15.
    Liu, Z., Chen, K., Davis, C., Sherlock, S., Qizhen, C., Chen, X., et al. (2008). Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Research, 68, 6652–6658.CrossRefGoogle Scholar
  16. 16.
    Dai, H. (2002). Carbon nanotubes: Synthesis, integration, and properties. Accounts of Chemical Research, 35, 1035–1044.CrossRefGoogle Scholar
  17. 17.
    Van Tassel, K., & Goldman, R. (2010). Manufacturing the wings of icarus: FDA regulation of nanotechnology used in products for human consumption including food, dietary supplements, cosmetics and sunscreens. Journal of Law, Technology and Policy, 32, 2140–2183.Google Scholar
  18. 18.
    Jaracz, S., Chen, J., Kuznetsova, V. L., & Ojima, I. (2005). Recent advances in tumour targeting anticancer drug conjugates. Bioorganic & Medicinal Chemistry, 13, 5043–5054.CrossRefGoogle Scholar
  19. 19.
    Dhar, S., Liu, Z., Thomale, J., Dai, H., & Lippard, J. S. (2008). Targeted single-wall carbon nanotube-mediated Pt (IV) prodrug delivery using folate as a homing device. Journal of American Chemical Society, 130, 11467–11476.CrossRefGoogle Scholar
  20. 20.
    Low, P. S., & Antony, A. C. (2004). Folate receptor targeted drugs for cancer and inflammatory disease. Advanced Drug Delivery Review, 56, 1057–1238.CrossRefGoogle Scholar
  21. 21.
    Shim, M., Kam, W. S. N., Chen, J. R., Li, Y., & Dai, H. (2002). Functionalization of carbon nanotubes for biocompatibility and biomolecular recognition. Nanoletters, 2, 285–288.CrossRefGoogle Scholar
  22. 22.
    Antony, A. C. (1996). Folate receptors. Annual Review of Nutrition, 16, 501–521.CrossRefGoogle Scholar
  23. 23.
    Nie, H., Wei, G., Yuan, Y., Dou, Z., Zujin, S., Liu, Z., et al. (2010). PEGylation of double-walled carbon nanotubes for increasing their solubility in water. Nanoresearch, 3, 103–109.Google Scholar
  24. 24.
    Prencipe, G., Tabakman, M. S., Welsher, K., Liu, Z., Goodwin, P. A., Zhang, L., et al. (2009). PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. Journal of American Chemical Society, 131, 4787–4793.CrossRefGoogle Scholar
  25. 25.
    Veronese, F. M., & Mero, A. (2008). The impact of PEGylation on biological therapies. Biodrugs, 22, 315–329.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 2.5 International License (, which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Authors and Affiliations

  • Isma Ahmed
    • 1
  • Aneela Javeed
    • 1
  • Waqar Ahmed
    • 2
  • D. A. Phoenix
    • 3
  • Abdelbary Elhissi
    • 4
    Email author
  • Mark J. Jackson
    • 5
  1. 1.School of Pharmacy and Biomedical SciencesUniversity of Central LancashirePrestonUK
  2. 2.School of MedicineUniversity of Central LancashirePrestonUK
  3. 3.London South Bank UniversityLondonUK
  4. 4.Pharmaceutical Sciences SectionCollege of Pharmacy, Qatar UniversityDohaQatar
  5. 5.Kansas State UniversitySalinaUSA

Personalised recommendations